INTRODUCTION {#S1}
============

Circadian rhythms restrict physiological functions including sleep/wake, feeding, thermoregulation, and hormone release to appropriate temporal niches. This behavior is proximally controlled by cellular circadian clocks. During the cellular clock\'s rising phase, Bmal1/Clock heterodimers drive transcription of clock genes including *Per1/2/3* and *Cry1/2*, whose products inhibit their own transcription during the falling phase (reviewed in [@R4]).

Despite the ubiquity of cellular clocks in the body, the suprachiasmatic nucleus (SCN) of the anteroventral hypothalamus acts as a master regulator of light-entrained circadian rhythms, a role facilitated by a number of remarkable properties unique to its cells. In dispersed culture conditions, SCN neurons spontaneously synchronize their circadian clocks, unlike any other cell type ([@R28]). SCN slice cultures also sustain robust circadian oscillations for weeks, unlike most other neural regions ([@R1]; [@R57]). Finally, while the SCN is uniquely susceptible to direct phase-shifting by light signals from intrinsically photosensitive retinal ganglion cells (ipRGCs), it is exceptionally resistant to resetting by nonlight cues that phase-shift peripheral clocks ([@R11]; [@R24]). These properties rely on a robust SCN network that strengthens and coordinates the unstable oscillations of its individual cellular clocks, thereby organizing output signals that entrain the rest of the body ([@R4]; [@R17]; [@R50]; [@R60]; [@R62]).

Neuropeptides prominently and selectively expressed in the SCN are heavily implicated in the regulation of the SCN network. Vasoactive intestinal peptide (Vip) is a key organizer of SCN cellular rhythms and activity; genetic disruption of *Vip* or its receptor, *Vipr2*, reduces the proportion and synchrony of circadian SCN cells ([@R7]; [@R36], [@R37]) and disrupts SCN electrical activity rhythms ([@R10]) as well as circadian- and light-entrained locomotion ([@R7]; [@R19]; [@R22]). Another critical component is prokineticin-2 (Prok2), a major SCN output signal ([@R15]; [@R47]). Gastrin-releasing peptide (Grp) and arginine vasopressin (Avp) also contribute to SCN gene expression rhythms, electrical rhythms, and output, while enkephalin (Enk) may gate SCN responsiveness to light ([@R3]; [@R9]; [@R23]; [@R35]; [@R36], [@R37]; [@R39]; [@R59]; [@R63]). In mice, exogenous neuromedin S (Nms) alters circadian behavior but has unknown endogenous roles ([@R41]). Numerous other canonical neuropeptides are also present in SCN, and unbiased studies have identified dozens more whose characterization has only just begun ([@R2]; [@R6]; [@R33]).

SCN cellular heterogeneity implies complex developmental pathways guiding its differentiation and the emergence of its unique circadian properties. To date, three transcription factors involved in SCN development have been identified: *Six3*, *Six6*, and *Lhx2*. Deletion of any one of these factors prevents SCN specification from hypothalamic neuroepithelium ([@R18]; [@R51]; [@R58]). These factors are broadly expressed in developing ventral forebrain ([@R27]; [@R43]; [@R64]), and all SCN gene expression and structural markers are undetectable after their genetic disruption ([@R18]; [@R51]; [@R58]), providing little insight into later stages of SCN differentiation. Therefore, nothing is yet known about the transcriptional regulatory network controlling expression of SCN-enriched neuropeptides such as Vip and Avp.

Unlike *Six3*, *Six6*, and *Lhx2*, hypothalamic expression of other transcription factors is restricted to the SCN during development, the earliest of which is LIM homeodomain transcription factor 1 (Lhx1) ([@R55]; [@R58]). *Lhx1* guides differentiation of other neural subtypes outside the hypothalamus, including cerebellar Purkinje cells ([@R65]) and hindbrain reticulospinal neurons ([@R13]). Intriguingly, it also dictates neuropeptide fate of specific cell subpopulations during spinal cord development ([@R8]).

We find that *Lhx1* is necessary for SCN terminal differentiation, including expression of neuropeptides profoundly important for circadian function. Despite only modest changes in variability and synchronization of cellular rhythms, circadian locomotor activity rhythms were severely disorganized and vulnerable to neuropeptidergic disturbance of consolidation, phase, and period in mice with *Lhx1* selectively deleted in anterior hypothalamus. Our study identifies a transcription factor involved in SCN terminal differentiation. The *Six3-Cre;Lhx1*^lox/lox^ mouse also provides a behavioral model with several emergent properties not seen in animals with deficits in a single-neuropeptide pathway, providing insight into the synergistic nature of the SCN neuro-peptide network.

RESULTS {#S2}
=======

Selective Deletion of *Lhx1* in Ventral Anterior Hypothalamus {#S3}
-------------------------------------------------------------

Because conventional *Lhx1* null mice lack anterior neural structures ([@R54]), we used an intersectional approach to more specifically delete *Lhx1* in the developing anterior hypothalamus by crossing a conditional allele to transgenic *Six3-Cre* mice ([@R20]; [@R31]). As previously reported, *Six3-Cre* activity was more spatially restricted than native *Six3* expression ([@R20]). *Six3-Cre;ROSA26::YFP* mice had robust Cre activity in the ventral telencephalon and ventral anterior hypothalamus, including the SCN and subparaventricular zone (SPZ). However, *Six3-Cre;ROSA26::YFP* mice lacked Cre activity in more posterior regions that express *Lhx1* during embryonic development, such as the intergeniculate leaflet (IGL), dorsomedial hypothalamus, and mamillary nucleus ([Figures S1A and S1B](#SD1){ref-type="supplementary-material"}). *Lhx1* in situ hybridization (ISH) revealed that *Six3-Cre;Lhx1*^lox/lox^ mice reliably and specifically lost *Lhx1* expression in the ventral anterior hypothalamus, including the SCN and SPZ ([Figures S1C--S1E and S1I](#SD1){ref-type="supplementary-material"}). Although transient *Lhx1* expression in anterior hypothalamic nucleus and anterior lateral hypothalamus were also lost at postnatal day 0 (P0) ([Figure S1I](#SD1){ref-type="supplementary-material"}), neither region has any established circa-dian function. *Lhx1* was normally expressed in more posterior regions important for circadian rhythmicity and motor output (e.g., IGL, cerebellum) as well as the medial preoptic area ([Figures S1F--S1H](#SD1){ref-type="supplementary-material"}).

*Lhx1* Deletion Disrupts SCN-Enriched Neuropeptide Expression {#S4}
-------------------------------------------------------------

We next examined neuropeptide expression in *Six3-Cre; Lhx1*^lox/lox^ and *Lhx1*^lox/lox^ control SCN by ISH. Neuropeptides implicated in circadian function were downregulated ([Figures 1A--1G](#F1){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}), including *Vip*, *Prok2*, *Grp*, *Avp*, *Enk*, and *Nms* (p \< 0.05 for all except Grp, and p \< 0.005 for Grp). Down-regulation was not observed in other brain regions ([Figures 1A-- 1F](#F1){ref-type="fig"}). SCN neuropeptide loss was not caused by the Cre driver alone, because *Six3-Cre;Lhx1*^+/+^ mice had normal expression of *Vip*, *Grp*, *Avp*, and *Lhx1* ([Figures S1J--S1M](#SD1){ref-type="supplementary-material"}).

Importantly, other SCN markers were largely unaffected by *Lhx1* deletion ([Figures 2](#F2){ref-type="fig"} and [S2](#SD1){ref-type="supplementary-material"}). GABAergic markers such as *Gad67*, *Calb1*, and *Calb2* were retained ([Figures 2A--2C](#F2){ref-type="fig"}), as were SCN markers first expressed prior to induction of circadian neuropeptides during development, such as *Vipr2*, *Id4*, *Arx*, *Dlx2*, *Nr1d1*, and *Rorb* ([Figures 2D](#F2){ref-type="fig"} and [S2A--S2E](#SD1){ref-type="supplementary-material"}). Neuropep-tides broadly expressed in the anterior hypothalamus were also mostly preserved in *Six3-Cre;Lhx1*^lox/lox^ SCN, including *Sst*, *Agt*, *Nts*, *Cck*, *Gal*, and *Scg2* ([Figures S2F--S2K](#SD1){ref-type="supplementary-material"}). Expression of *Pcsk1n*, required for proteolytic processing of many neuro-peptide precursors, is also preserved ([Figure S2L](#SD1){ref-type="supplementary-material"}). Importantly, most markers normally restricted to specific SCN subdomains showed similar compartmentalization in mutants. For instance, *Calb2* localized to ventral core, *Rorb* localized to shell, and *Vipr2* expression remained weak in the center of the SCN ([Figures 2C and 2D](#F2){ref-type="fig"} and [S2E](#SD1){ref-type="supplementary-material"}).

*Lhx1* Deletion Causes Neuron Loss and Cell Death in Developing SCN {#S5}
-------------------------------------------------------------------

Pan-SCN ISH markers showed that *Six3-Cre;Lhx1*^lox/lox^ SCN was smaller than controls; therefore, we performed immunohistochemistry (IHC) for the pan-neuronal marker HuC/D and found that SCN neuron number was significantly reduced in *Six3-Cre;Lhx1*^lox/lox^ adults (p \< 0.05). To determine when neuron loss occurred in *Six3-Cre;Lhx1*^lox/lox^ SCN, we conducted HuC/D IHC at multiple developmental time points ([Figures 2E](#F2){ref-type="fig"} and [S3M](#SD1){ref-type="supplementary-material"}). There were main effects of both genotype and age (p \< 0.0005) and significant interaction (p \< 0.05). SCN neuron number was normal at P0 in *Six3-Cre;Lhx1*^lox/lox^ mice (p = 0.95), but significantly fewer SCN neurons were present by P4 in *Six3-Cre;Lhx1*^lox/lox^ SCN compared to controls (p \< 0.0005) ([Figures 2E](#F2){ref-type="fig"} and [S2M](#SD1){ref-type="supplementary-material"}). No further loss of neurons was observed in *Six3-Cre;Lhx1*^lox/lox^ SCN after P4, although neuron number continued to decrease gradually in control SCN into adulthood (p \< 0.05); this dropped the previously noted genotype difference in adult neuron number slightly below significance (p = 0.07) in the context of the time course.

To examine whether decreased neuron number between P0 and P4 in *Lhx1*-deficient SCN resulted from increased developmental apoptosis, we conducted TUNEL experiments in P0--P3 SCN. A main effect of genotype (p \< 0.005) indicated an aggre-gate increase in TUNEL-positive cells across the time course in *Six3-Cre; Lhx1*^lox/lox^ SCN, although no individual time points were significant ([Figures 2F](#F2){ref-type="fig"} and [S2N](#SD1){ref-type="supplementary-material"}). There was also a main effect of age (p \< 0.0005) but no interaction (p = 0.30).

Reduction in Neuropeptide Gene Expression Is Not Caused by Selective Neuron Loss in *Lhx1*-Deficient SCN {#S6}
--------------------------------------------------------------------------------------------------------

To examine whether neuron loss could explain SCN neuropeptide depletion in our mutants, we measured neuropeptide expression by ISH at P0, when *Six3-Cre;Lhx1*^lox/lox^ SCN neuron number is normal ([Figures 2G](#F2){ref-type="fig"} and [S2O--S2R](#SD1){ref-type="supplementary-material"}). *Vip*, *Avp*, and *Grp* were already profoundly downregulated in mutant SCN, indicating that loss of neuropeptide gene expression precedes neuron loss (all p \< 0.05; [Figure 2G](#F2){ref-type="fig"}). *Prok2* expression was very low and variable in controls, making comparison with mutants uninterpretable ([Figure 2G](#F2){ref-type="fig"}). We did not detect *Enk* or *Nms* in control or mutant SCN by ISH at P0 (data not shown).

We then conducted in silico MOPAT analysis to determine whether Lhx1 might directly regulate expression of SCN-enriched neuropeptides. A greater proportion of evolutionarily conserved predicted Lhx1 consensus binding sites were present within proximal regulatory regions of SCN-enriched genes relative to randomly selected genes ([Figure 1H](#F1){ref-type="fig"}). SCN-enriched genes bearing putative Lhx1 binding sites included the three neuropep-tide genes with the greatest percent reduction in *Six3-Cre; Lhx1*^lox/lox^ mice (*Vip*, *Prok2*, and *Nms*) as well as *Enk*, which was not included in our initial analysis ([Figures 1G and 1H](#F1){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}).

SCN Clock Gene Expression Rhythms Are Preserved after *Lhx1* Deletion {#S7}
---------------------------------------------------------------------

Despite profoundly decreased neuropeptide expression, bioluminescence recordings from *Six3-Cre;Lhx1*^lox/lox^*;Per2^luc/+^* SCN cultures revealed clock gene rhythms with similar circadian period compared to controls from two independently tested groups of mice. Mean bioluminescence was similar in the first cohort but lower in the experimental group in the second cohort (Mann-Whitney *U* test, p \< 0.01). *Lhx1*-deficient SCN had reduced peak-to-trough Per2 rhythm amplitude and more rapid damping in both cohorts (p \< 0.05, Student\'s t test; [Figure 3A](#F3){ref-type="fig"}). Higher-resolution charge-coupled device (CCD) camera data revealed that this was attributable to reduced circadian synchrony ([Figure 3B](#F3){ref-type="fig"}) and increased circadian period variability within each *Six3-Cre;Lhx1*^lox/lox^ SCN relative to controls (p \< 0.001, Student\'s t test; [Figure 3C](#F3){ref-type="fig"}).

We confirmed a similar pattern in vivo via a 24 hr ISH time course of the core clock genes *Per1* and *Per2* and the clock-controlled gene *Avp*. There were main effects of circadian time for all three genes tested in *Six3-Cre;Lhx1*^lox/lox^ SCN and controls in constant darkness (DD) (*Per1* p \< 0.001; *Per2* p \< 0.0001; *Avp* p \< 0.0001) ([Figures 3D--3F](#F3){ref-type="fig"} and [S3A--S3C](#SD1){ref-type="supplementary-material"}). A main effect of genotype and an interaction were observed for *Per2* (p \< 0.0001, p \< 0.01) and *Avp* (both p \< 0.0001), but not *Per1* (p = 0.09, p = 0.27) ([Figures 3D--3F](#F3){ref-type="fig"} and [S3A--S3C](#SD1){ref-type="supplementary-material"}). *Vip* mRNA was also examined but was virtually absent at all circadian time points (data not shown). Thus, both core clock and clock-controlled gene expression is still temporally regulated over circadian time, albeit with reduced amplitude for some genes, in the SCNs of intact *Six3-Cre;Lhx1*^lox/lox^ mice.

Disrupted Circadian Activity Rhythms in *Lhx1*-Deficient Mice {#S8}
-------------------------------------------------------------

Because lower-amplitude oscillations more readily phase shift to out-of-phase light exposure ([@R48]), we reasoned that *Six3-Cre;Lhx1*^lox/lox^ animals would more readily entrain and reset to light cues than controls. Instead, activity of *Six3-Cre;Lhx1*^lox/lox^ mice entrained less robustly than controls under a 12:12 light:dark cycle (LD) ([Figure 4A](#F4){ref-type="fig"}), with a small advanced phase angle of nocturnal wheel running into the light phase and a reduced percentage of overall activity confined to the dark phase ([Figures 4B and 4C](#F4){ref-type="fig"}). In many ways, these LD phenotypes seem similar to those seen in *Vip*^−/−^ mice, leading us to initially hypothesize that *Vip* loss alone underpinned the behavioral deficits of *Six3-Cre;Lhx1*^lox/lox^ mutants.

However, this proved incomplete when we examined the animals in DD. Despite moderate damping and desynchrony phenotypes in *Lhx1*-deficient SCN similar to or milder than previous descriptions of *Vip*^−/−^ and *Vipr2*^−/−^ SCN rhythms ([@R7]; [@R10]; [@R37]), free-running activity rhythms of *Lhx1*-deficient mice were profoundly disorganized ([Figure 4D](#F4){ref-type="fig"}). A total of 50% of *Six3-Cre;Lhx1*^lox/lox^ mice lacked measurable rhythms within 3 days of entry into DD, while the remainder showed two or even three distinct split rhythms, sometimes of dramatically different periods ([Figure 4F](#F4){ref-type="fig"}). In contrast, 13% of *Vip*^−/−^ mice on a similar mixed background became arrhythmic within 3 days of entry into DD; this increased only to 26% of *Vip*^−/−^ mice over the course of several weeks in DD ([@R19]). A subsequent study of *Vip*^−/−^ mice backcrossed to C57BL/6 found that 64% of these animals had badly disrupted rhythms, but most were multirhythmic, not arrhythmic ([@R7]).

When a behavioral rhythm is measurable, *Six3-Cre;Lhx1*^lox/lox^ free-running rhythms often lacked a clearly dominant rhythm and were not of significantly different average period than controls, although individual variability in period length was markedly greater ([Figure 4E](#F4){ref-type="fig"}). This is in contrast to *Vip*^−/−^ mice, which regardless of genetic background consistently have a clear dominant rhythm with a significantly shorter period than wild-type mice ([@R7]; [@R19]).

Advanced phase angle and increased activity during the LD light phase also suggested *Six3-Cre;Lhx1*^lox/lox^ mice have defects in light-dependent activity suppression. Although such a decrease was supported by the observation that overall activity in constant light (LL) and DD was similar, we noticed a substantial decrease in activity in mutants under DD relative to controls ([Figure 4G](#F4){ref-type="fig"}), precluding a conclusion about masking from these data alone. To more rigorously measure masking, we first examined acute activity suppression of wheel-running activity by a 3 hr light pulse from zeitgeber time (ZT) 14--17 and found no significant difference in masking in *Lhx1*^lox/lox^ and *Six3-Cre;Lhx1*^lox/lox^ mice ([Figure S4G](#SD1){ref-type="supplementary-material"}). We then examined masking under an ultradian light cycle (3.5 hr light: 3.5 hr dark). Mice do not entrain to this cycle; instead, light pulses suppress wheel-running activity, permitting separation of light-masking effects from photoentrainment. The percentage of activity during the dark portion of the ultradian cycle in *Lhx1*^lox/lox^ and *Six3-Cre;Lhx1*^lox/lox^ mice was similar ([Figure S4H](#SD1){ref-type="supplementary-material"}). Interestingly, masking does not require the SCN ([@R49]), indicating that specifically SCN-mediated circadian behaviors are impaired in this mouse line. This again contrasts with *Vip*^−/−^ mice, which show substantially elevated activity in response to a dark pulse ([@R19]).

Taken together, these data show that *Six3-Cre;Lhx1*^lox/lox^ mice have disrupted circadian behavior including abnormal photoentrainment and disrupted free running rhythms, with the latter seeming substantially more severe than in *Vip*^−/−^ mice. However, light-dependent masking of locomotor activity is normal in our mice.

Intact IpRGC Innervation of SCN After *Lhx1* Deletion {#S9}
-----------------------------------------------------

The abnormal photoentrainment but intact masking of *Six3-Cre;Lhx1^lox/^*^lox^ mice then led us to investigate whether Lhx1 loss altered retinal innervation of SCN. We utilized the Opn4^tau-LacZ^ mouse to selectively label ipRGCs by X-gal staining ([@R21]; [@R24]). *Six3-Cre;Lhx1^lox/^*^lox^; *Opn4^taulacZ/+^* mutants and *Lhx1*^lox/lox^*;Opn4^taulacZ/+^* controls had similar gross innervation of SCN, olivary pretectal nucleus, and lateral geniculate nucleus ([Figures S4A and S4B](#SD1){ref-type="supplementary-material"}). This was corroborated by labeling all RGCs using intravitreal cholera toxin tract tracing in *Six3-Cre;Lhx1*^lox/lox^ mice and controls ([Figures S4C and S4D](#SD1){ref-type="supplementary-material"}). We then measured pupillary light reflex and visual acuity (optokinetic response) to assess the function of ipRGCs and RGCs, respectively. We found that ipRGCs are functional in *Six3-Cre;Lhx1*^lox/lox^ mice, because pupillary light reflex was comparable to controls under both dim and bright light ([Figure S4E](#SD1){ref-type="supplementary-material"}). *Six3-Cre;Lhx1*^lox/lox^ mice also show an optokinetic response, but we observed a small but significant reduction in visual acuity ([Figure S4F](#SD1){ref-type="supplementary-material"}). This is likely due to defects in horizontal cell lamination known to occur after *Lhx1* deletion in the developing retina ([@R46]), which is targeted by our Cre driver ([@R20]). Lhx1 does not play a specific role in the development of any other retinal cell type. Taken together, these results suggest that deficits in locomotor activity of *Six3-Cre;Lhx1*^lox/lox^ mice were not a result of abnormal retinal input to the SCN.

Behavioral Rhythms of *Six3-Cre;Lhx1*^lox/lox^ Mice Are Hypersensitive to Pulses of the SCN Synchronizing Neuropeptide Grp and Output Neuropeptide Prok2 {#S10}
--------------------------------------------------------------------------------------------------------------------------------------------------------

Given the low-amplitude but persistent molecular and cellular rhythms in *Lhx1*-deficient SCN, we hypothesized that an in vivo pulse of Grp, known to synchronize disorganized SCN cellular oscillators in culture ([@R9]; [@R37]), should consolidate our mutants' behavioral rhythms. To allow approximate calculation of circadian time (CT) for the injections, we selected *Six3-Cre;Lhx1*^lox/lox^ mice exhibiting the mildest subset of splitting phenotypes, including one exceptional mouse that usually exhibited essentially wild-type behavior, for our cannulation studies ([Figures 5A, 5B](#F5){ref-type="fig"}, and [S5A--S5C](#SD1){ref-type="supplementary-material"}). When ISH was subsequently performed on the SCNs of the cannulated cohort, higher numbers of cells appeared to be both *Lhx1* positive and neuropeptide positive than in previously examined *Six3-Cre;Lhx1*^lox/lox^ mice ([Figure S5D](#SD1){ref-type="supplementary-material"}). This suggested that lower Cre efficiency was responsible for the better-preserved rhythms of these animals.

We first determined that an intracerebroventricular (i.c.v.) saline injection produced no effect regardless of genotype ([Figure 5A](#F5){ref-type="fig"}). Control mice exhibited phase shifts after Grp cannulation (--0.55 hr ± 0.26, p \< 0.05, one-tailed paired Student\'s t test), consistent with previous work ([@R44]) ([Figures 5B](#F5){ref-type="fig"} and [S5A](#SD1){ref-type="supplementary-material"}). Acute inhibition of locomotion was also often observed ([Figure S5A](#SD1){ref-type="supplementary-material"}). Surprisingly, visual inspection of acto-grams from *Six3-Cre;Lhx1*^lox/lox^ mice after i.c.v. Grp injection showed considerable deconsolidation of activity rhythms ([Figures 5B'](#F5){ref-type="fig"} and [S5A'](#SD1){ref-type="supplementary-material"}). To quantify this, we compared the number of animals of both genotypes with measurable circadian phase before, but not following, Grp administration. We found a significant deleterious effect of Grp on mutant activity rhythms (post-injection phase measurable after 7/7 control injections versus 1/5 mutant injections, Fisher\'s exact test, p = 0.01).

Given the dramatic deconsolidating effect of Grp, we hypothesized that Lhx1-deficient SCN might be sensitive to pulses of SCN output neuropeptides that do not normally produce phase changes in wild-type animals. We tested this by i.c.v. injection of the SCN output neuropeptide Prok2. We found that i.c.v. Prok2 cannulation acutely inhibited locomotion without affecting either phase or period in control mice, as previously observed in rat ([Figures 5C](#F5){ref-type="fig"} and [S5B](#SD1){ref-type="supplementary-material"}; [@R15]). Remarkably, Prok2 significantly altered not just phase but also period in *Six3-Cre;Lhx1*^lox/lox^ mice (p \< 0.05; [Figures 5C--5E](#F5){ref-type="fig"} and [S5B'](#SD1){ref-type="supplementary-material"}). Period shift after a single injection often lasted for many cycles ([Figure S5B'](#SD1){ref-type="supplementary-material"}). When rhythms were robust enough to calculate a more accurate post hoc circadian time of the injection (5/8 injections), there was clear circadian gating of both period shift (r^2^ = 0.82) and phase shift (r^2^ = 0.56), with the largest shifts occurring closest to the target injection time of CT14 ([Figures 5D and 5E](#F5){ref-type="fig"}).

A prediction from these studies is that Prok2 will produce larger shifts in phase and period in mutant mice with the greatest reduction of SCN neuropeptides. The number of neuropeptidergic cells in *Six3-Cre;Lhx1*^lox/lox^ SCN correlated well with the magnitude of phase shifts of mutant mice after Prok2 injection (r^2^ = 0.92 \[Vip\], r^2^ = 0.88 \[Grp\], r^2^ = 0.86 \[Avp\]) and, to some extent, also with their period shifts (r^2^ = 0.76 \[Vip\], r^2^ = 0.43 \[Grp\], r^2^ = 0.38 \[Avp\]). While fewer Vip and Grp cells correlated with larger phase and period shifts, Avp cell number had the opposite relationship ([Figures S5D and S5E](#SD1){ref-type="supplementary-material"}). In sum, our cannulation studies highlighted the importance of the SCN neuropep-tide network for buffering and transforming the circadian effects of its own signaling molecules.

DISCUSSION {#S11}
==========

*Lhx1* Controls Terminal Differentiation of SCN Neurons {#S12}
-------------------------------------------------------

In this study, we found that *Lhx1* deletion dramatically downregulates expression of several SCN-enriched neuropeptides crucial for circadian function ([Figure 1](#F1){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}). However, the expression of pan-neuronal, GABAergic interneuron and other genes broadly expressed in anterior hypothalamus is largely intact in *Six3-Cre;Lhx1*^lox/lox^ SCN, as are SCN-specific genes first detectable prior to embryonic day 16.5 (E16.5) ([Figures 2A--2D](#F2){ref-type="fig"} and [S2A--S2L](#SD1){ref-type="supplementary-material"}). This suggests that transcriptional networks regulating regional identity, neuropeptidergic and GABAergic cell fate are separate developmental programs in the SCN. This contrasts with the only other neural system where Lhx1 is known to dictate neuropeptidergic fate; in spinal cord inhibitory interneurons, Lhx1 both drives *Npy* and *Enk* expression in conjunction with Lhx5 ([@R8]) and helps maintain GABAergic fate ([@R45]). *Lhx5* is not expressed in developing mammalian SCN, which may lead to *Lhx1*-dependent, SCN-specific expression of neuropeptides different from those in spinal interneurons ([@R8]).

While *Lhx1* deletion also causes a comparatively moderate loss of neurons by P4 ([Figures 2E](#F2){ref-type="fig"} and [S2M](#SD1){ref-type="supplementary-material"}), the region\'s gross anatomy remains essentially intact, with most surviving domain-specific markers retaining normal compartmentalization ([Figures 2A--2D](#F2){ref-type="fig"} and [S2A--S2L](#SD1){ref-type="supplementary-material"}). Because SCN neurogenesis is mostly complete by E16 and TUNEL revealed elevated cell death in *Lhx1*-deficient SCN between P0 and P3 ([Figures 2F](#F2){ref-type="fig"} and [S2N](#SD1){ref-type="supplementary-material"}), increased neuronal apoptosis likely decreased neuron number. Apoptosis also increased between P0 and P3 in both control and mutant SCN. This is in line with the timing of peak cell death in hamster SCN, which immediately precedes innervation by the retinohypothalamic tract ([@R42]). Neuron loss does not cause SCN neuropeptide downregulation, because many neuropeptidergic populations lost in adult *Lhx1*-deficient SCN (*Vip*, *Avp*, *Grp*, and possibly *Prok2*) are already reduced in *Lhx1*-deficient SCN at P0, prior to neuron loss ([Figures 2G](#F2){ref-type="fig"} and [S2O--S2R](#SD1){ref-type="supplementary-material"}). Taken together, these data indicate that increased apoptosis and neuron loss are likely secondary to defects in SCN terminal differentiation in *Six3-Cre;Lhx1*^lox/lox^ SCN.

Given that Lhx1 is first detectable at E11.5 when SCN neurogenesis begins, we initially hypothesized that *Six3-Cre; Lhx1*^lox/lox^ mice would have an early SCN specification defect, akin to neuronal progenitor-specific deletion of *Six3* ([@R58]) or constitutive deletion of *Six6* or *Lhx2* ([@R18]; [@R51]), rather than a terminal differentiation defect. Preservation of early-onset markers in *Lhx1* mutants suggests that any role of Lhx1 in early SCN differentiation is redundant with other factors up to E16.5. One candidate is *Lhx8*, a close *Lhx1* homolog coexpressed with Lhx1 in developing SCN from E11.5 until E16.5, when *Lhx8* is downregulated ([@R55]). Future analysis of *Lhx1/Lhx8* double mutants should resolve whether the latter is partially compensating for *Lhx1* deletion.

More broadly, Lhx1\'s central role in terminal differentiation of multiple neuropeptidergic cell types in SCN presents an opportunity to dissect the transcriptional network guiding SCN cell fate determination. Leveraging this starting point, future investigations will be able to isolate both upstream regulators of *Lhx1* expression and downstream factors that further subdivide SCN neuropeptidergic populations. Combined with identification of factors involved in initial SCN specification, such as *Six3*, *Six6*, and *Lhx2* ([@R18]; [@R51]; [@R58]), this line of study could eventually allow stem cell lineages to be differentiated into specific SCN cell types, with profound implications for treatment of circadian-related sleep disturbances, mood disorders, and other pathologies.

*Lhx1* Is Required for Normal SCN Cellular and Behavioral Rhythmicity {#S13}
---------------------------------------------------------------------

Despite loss of expression of multiple neuropeptides involved in synchronization of SCN oscillators in *Six3-Cre;Lhx1*^lox/lox^ mice, rhythms of Per2::luciferase expression in SCN slice cultures showed normal average period and only moderately damped amplitude ([Figure 3A](#F3){ref-type="fig"}). CCD imaging showed this was due to reduced cellular synchrony and increased period variability in *Lhx1*-deficient SCN ([Figure 3B-C](#F3){ref-type="fig"}). Furthermore, our ISH time course showed that clock and clock-controlled gene expression is still temporally regulated in vivo after *Lhx1* deletion ([Figures 3D--3F](#F3){ref-type="fig"} and [S3A--S3C](#SD1){ref-type="supplementary-material"}). These deficits are similar to what has been observed shortly after culturing *Vipr2*^−/−^ SCN slices ([@R10]).

The severe circadian deficits in *Six3-Cre;Lhx1*^lox/lox^ DD activity rhythms were unexpected given the moderate effects on SCN oscillators in these animals ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Although some mutants had milder splitting phenotypes ([Figures 4F](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [S5A, and S5B](#SD1){ref-type="supplementary-material"}), most had multiple rhythms with distinct periods or had no measurable rhythms at all ([Figures 4D and 4F](#F4){ref-type="fig"}). Typically, behavioral rhythms are more, not less, well organized than those of cellular clocks ([@R7]; [@R19]; [@R22]), making our observations unusual. Severe behavioral disorganization, normal average circadian period, a lack of altered activity rhythm masking by darkness, and the disconnect between robustness of cellular and behavioral rhythms all suggest that the phenotype of *Lhx1* deletion in SCN is not simply a product of *Vip* loss ([@R7]; [@R19]).

The most likely explanation rationalizing our SCN clock and behavioral data is that loss of expression of SCN neuropeptides following *Lhx1* deletion leads the SCN to become not only internally disorganized but also uncoupled from downstream oscillators in the absence of external light cues. This suggests that Lhx1-regulated neuropeptide(s) and/or other signals could constitute the unidentified paracrine signals proposed to be sufficient for synchronization of peripheral oscillators by SCN ([@R56]). *Prok2* is one likely component, because *Prok2*^−/−^ SCN also seems to have a reduced ability to drive circadian rhythms ([@R34]); however, the low percentages of *Prok2*^−/−^ mice with severely disrupted rhythms (13% in mixed background and 20% after backcrossing to C57BL/6) suggest that it alone cannot account for the entirety of the *Six3-Cre; Lhx1*^lox/lox^ phenotype. On the other hand, phase-advanced photoentrainment in *Six3-Cre;Lhx1*^lox/lox^ mice, with an activity onset before dark, suggests that the *Lhx1*-deficient SCN does engage downstream oscillators when driven by light. Light entrainment may coordinate remaining SCN outputs, such as GABA ([@R40]), to preserve activity rhythms under light-dark conditions.

Finally, *Lhx1*-deficient mice did not decrease their activity in response to constant light, reflecting a decrease in overall activity ([Figure 4G](#F4){ref-type="fig"}), despite having intact masking ([Figures S4G and S4H](#SD1){ref-type="supplementary-material"}). IpRGCs do not appear to contribute to this defect; they are functional and innervate their targets normally ([Figures S4A--S4D](#SD1){ref-type="supplementary-material"}). Both *Vip*^−/−^ and *Prok2*^−/−^ mice have decreased overall activity levels under DD ([@R19]; [@R34]); loss of these and other neuropeptides following *Lhx1* deletion may act synergistically to drop DD activity to the same low, common baseline seen in wild-type mice in LL.

Implications for SCN Clock Function {#S14}
-----------------------------------

Induction of arrhythmicity in *Six3-Cre;Lhx1*^lox/lox^ mice given i.c.v. Grp ([Figure 5B](#F5){ref-type="fig"}) suggests that whether a given neuropeptide promotes synchronization or desynchronization is not an intrinsic property of the molecule and its receptors alone. Instead, the effects of a given neuropeptide on synchrony also seem to depend on interpretation by the broader SCN neuropeptide network. It is known that large doses of Vip can transiently disrupt rhythms in normal mice, both in slice culture and in vivo, but that even very high doses of Grp fail to mimic this effect ([@R5]), and it has long been known that normal mice merely phase shift in response to exogenous Grp ([@R44]). Based on the literature, one would expect excess Grp to help consolidate activity in *Lhx1*-deficient mice, as it does in slice cultures of *Vip*^−/−^ SCN ([@R9]; [@R37]). Instead, quite the opposite occurs, suggesting that another signaling molecule(s) present in the *Vip*^−/−^ SCN underpins Grp\'s synchrony-promoting activity.

Similarly, after i.c.v. Prok2 injection in *Six3-Cre;Lhx1*^lox/lox^ mice, dramatic changes in not just phase-shift magnitude, as might be predicted when the SCN oscillator is damped ([@R61]), but also period length ([Figures 5C--5E](#F5){ref-type="fig"} and [S5C-- S5E](#SD1){ref-type="supplementary-material"}) were surprising. This neuropeptide has no effect on phase or period in wild-type animals ([@R15]), which we reproduce in our study. The dramatic differences in the effects of Prok2 infusion in wild-type and *Lhx1*-deficient mice indicate a previously unappreciated *Lhx1*-dependent role for the SCN in buffering changes in phase and period induced by infusion of SCN-derived output neuropeptides. This provides insight into a central problem faced by the SCN: how to prevent changes in the central oscillator induced by both its own activity and afferent inputs from other brain regions, some of which use the same neurotransmitters, including Prok2 ([@R16]; [@R29]).

We propose that period buffering is at least partially mediated by the core neuropeptides Vip and Grp. Their mRNA expression negatively correlated with the magnitude of both phase and period changes after i.c.v. Prok2 infusion ([Figures S5D and S5E](#SD1){ref-type="supplementary-material"}), consistent with extending the peptides' well-documented ability to increase central oscillator robustness and thus control of circadian phase ([@R30]; [@R38]; [@R44]) to stabilization of circadian period in the face of perturbation by SCN output molecules. Meanwhile, expression of *Avp* positively correlated with both phase-shift magnitude and change in period length ([Figure S5D and S5E](#SD1){ref-type="supplementary-material"}), consistent with its role in relaying circadian clock signals to the SCN core ([@R32]; [@R53]). To what extent the in vivo circadian system is susceptible to Prok2 infusion when only core neuropeptides are lost, as in the *Vip*^−/−^ mouse, presents an interesting question for future study.

In sum, our functional findings may explain why the SCN selectively expresses so many different neuropeptides, with signals from each individual neuropeptide cooperating to synergistically enhance behavioral stabilization ([Figure 5F](#F5){ref-type="fig"}). Because the SCN expresses at least half a dozen different neuropeptides that are absent or greatly reduced in *Six3-Cre;Lhx1*^lox/lox^ mice, this is a finding that is only readily obtainable using a developmental genetic approach that globally disrupts SCN neuropeptide expression and that would have been missed using conventional behavioral, pharmacological, or individual neuropeptide-mutation approaches.

Summary {#S15}
-------

Our work identifies distinct transcriptional networks selectively regulating SCN terminal differentiation, as opposed to initial SCN specification. Specifically, our study shows that *Lhx1* loss selectively disrupts SCN terminal differentiation, leading to a failure to induce many neuropeptides crucial for normal circadian function ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). This discovery provides an entry point to dissect the transcriptional networks underlying development of the master clock and eventually determine how the region acquires its many unique circadian properties during early post-natal life.

Despite profound disruption of many components of the neuropeptide network, *Six3-Cre;Lhx1*^lox/lox^ SCN rhythms are no more disrupted than those seen in *Vip*^−/−^ SCN; however, *Six3-Cre;Lhx1*^lox/lox^ mice show much more defective free-running circadian activity rhythms than anticipated from the disruption of their cellular clocks, particularly in the absence of light input ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). We believe that these phenotypes suggest a profound SCN output deficit in these animals; therefore, they will be useful for determining the contribution of multiple SCN neuropeptides in controlling coupling between the SCN and peripheral oscillators and the role of this coupling in regulating physiology and cognition.

Finally, our data extend the field\'s understanding of the highly interdependent nature of individual SCN neuropeptides' functions ([Figure 5F](#F5){ref-type="fig"}). The desynchronizing effects of exogenous Grp in our *Six3-Cre;Lhx1*^lox/lox^ mice suggest that interactions among SCN neuropeptide signals can completely transform the effect of some signals on behavioral synchrony. Furthermore, our Prok2 cannulation studies identify a role for Lhx1-dependent elements of the SCN network, likely including the core neuropep-tides Vip and Grp, in maintaining robust circadian period length, as well as phase, in response to changing levels of secreted SCN output neuropeptides such as Prok2.

EXPERIMENTAL PROCEDURES {#S16}
=======================

Animals and Housing {#S17}
-------------------

*Six3-Cre;Lhx1*^lox/lox^ and control *Lhx1*^lox/lox^ mice were used, with the following exceptions: *Six3-Cre;Lhx1*^lox/lox^;*Opn4^l^*^acZ/+^ and *Lhx1*^lox/lox^*;Opn4*^lacZ/+^ mice for X-gal staining, *Six3-Cre;Lhx1*^lox/lox^; *Per2*^luc/+^ and *Lhx1*^lox/lox^*;Per2*^luc/+^ mice for luciferase imaging, and *Six3-Cre;ROSA26*::YFP mice for Cre mapping. Genetically modified mice were provided by Y. Furuta (*Six3-Cre*), R. Behringer (*Lhx1*^lox/lox^), and Jackson Laboratories (*Per2*::*luc*). Behavioral studies used males; other experiments used both sexes. Except where otherwise noted, mice were on a 15 hr:9 hr light:dark cycle. All mice were mixed C57BL6/ Sv129 background. All controls were littermates. All procedures and care were approved by Johns Hopkins Institutional Animal Care and Use Committee, in line with National Institutes of Health guidelines for experimental animals.

Genotyping {#S18}
----------

Transnetyx conducted most genotyping using proprietary methods. Some floxed *Lhx1* alleles were genotyped as described previously ([@R31]), and some Cre was detected by presence of a \~300 bp band amplified using primers 5'-TTCCCGCAGAACCTGAAGAT-3' and 5'-CCCCA GAAATGCCAGATTAC-3'.

Tissue Collection and Preparation {#S19}
---------------------------------

Brains were dissected, fresh frozen in OCT (Tissue-Tek) at the desired age, and stored at −80° C. Each experimental/control pair was collected in the same session. Clock gene time course mice were entrained to LD, moved to DD for 24 hr, and sacrificed in 4 hr increments on DD day 2. Next, 25 mm serial sections were cut on a Leica CM3050-S cryostat, thaw mounted on Superfrost Plus slides (Fisher), and stored at −80°C. Five adjacent slide sets were prepared for ISH; two were prepared for IHC and TUNEL.

In Situ Hybridization {#S20}
---------------------

Probes were selected and tissue processed as previously described ([@R55]).

Immunohistochemistry {#S21}
--------------------

Slides were fixed in 4% paraformaldehyde in 13 PBS, blocked in Superblock (Thermo Scientific), and then incubated overnight at 4°C in 1:200 monoclonal mouse immunoglobulin G (IgG) 2b anti-human-HuC/D (Invitrogen) or 1:500 polyclonal rabbit IgG anti-GFP (Molecular Probes) in PBS (5% horse serum, 0.16% Triton X-100 in 1X PBS). Slides were then incubated in 1:500 goat anti-mouse Alexa 568 IgG (Molecular Probes) or 1:500 donkey anti-rabbit Alexa 488 IgG (Molecular Probes), DAPI stained, and coverslipped with Gelvatol.

TUNEL Assay {#S22}
-----------

Slides were processed with TMR Red In Situ Cell Death Kit (Roche) following the manufacturer\'s instructions for cryopreserved tissue.

X-Gal Stain {#S23}
-----------

Slides were processed as described previously ([@R24]).

Cholera Toxin Labeling {#S24}
----------------------

Mice were anesthetized with Avertin (20 mg/ml). Eyes were injected intravitreally with 2 ml cholera toxin B subunit (CTb) conjugated to Alexa Fluor 488 (Invitrogen). Three days later, mice were deeply anesthetized with 1 ml Avertin and transcardially perfused with 4% formalin. Brains were removed, postfixed 2 hr in 4% formalin, cryoprotected in 30% sucrose, and frozen in OCT (Tissue-Tek). Next, 50 mm sections were cut and free-floated in 0.1 M phosphate buffer, blocked (0.1 M phosphate buffer, 3% Triton X-100, 0.5% BSA, 1.5% rabbit serum) for 1 hr, incubated in goat anti-CTb (List Biologicals, 1:8,000) overnight at 4°C, and visualized with rabbit anti-goat Vectastain horseradish peroxidase kit (Vector Labs) using 3,3-diaminobenzidine (Sigma). Sections were mounted, dehydrated, and coverslipped with Permount and then viewed on a Zeiss Axio Imager M1 microscope.

Cell Counting {#S25}
-------------

Slides were imaged by epifluorescence or bright field (Axioskop 2 Mot Plus, Zeiss Microscopy). After blinded manual counting of labeled SCN cells, total cells per hemisphere were estimated. Three brains per genotype per marker were counted. Statistical analysis was done in Excel (paired two-way t test) or Prism (two-way ANOVA with Tukey post hoc tests).

Circadian Time Course Densitometry {#S26}
----------------------------------

Slides were imaged by bright field (Axioskop 2 Mot Plus, Zeiss Microscopy) and analyzed in ImageJ. Rolling ball correction was applied to reduce background. Signal intensity from 0 to 255 arbitrary units was calculated in both SCN hemispheres and two cell-poor areas per image. Intensity of cell-poor regions was subtracted from SCN intensity, and mean and SEM d-intensity for each brain was computed in Excel. Two-way ANOVA analysis was done in Prism. Three brains per genotype per time point were used.

Real-Time Per2::Luciferase Measurement and Analysis {#S27}
---------------------------------------------------

SCN slices were cultured and maintained at 36°C in darkness. Bioluminescence from each culture was either integrated every minute with a photomultiplier tube or for 15 s every 10 min with a CCD camera. Photomultiplier tube data were analyzed using modified published methods ([@R25]). CCD data were stacked as previously described ([@R52]) and analyzed over 101 2 3 2 pixel regions of interest. See [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"} for details.

Wheel-Running Activity {#S28}
----------------------

Mice were housed individually with a 4.5-inch running wheel and ad libitum food and water. Wheel running was monitored using Vitalview (Mini Mitter). Photoentrainment was assayed in a 12 hr:12 hr light:dark cycle (LD). Free-running circadian rhythms were assessed in constant darkness (DD) and constant light (LL). Light intensity in LD and LL was \~600 lux, provided by Philips Daylight deluxe fluorescent lamps. Clocklab (Actimetrics) was used to generate actograms and measure circadian periods. A 3 hr light pulse from ZT 14--17 was used to measure acute activity suppression (masking) by light. Wheel revolutions were quantified during the pulse and normalized to the previous day where mice were undisturbed in the dark. A 1-week 3.5 hr:3.5 hr light:dark ultradian light cycle was also used to measure masking. Wheel revolutions were quantified to determine total activity during light and dark phases. Data were analyzed by Student\'s t test.

Stereotaxic Cannulation and i.c.v. Injections {#S29}
---------------------------------------------

Surgeries and targeting validation were performed as described previously ([@R12]). Briefly, unilateral cannulas were implanted in lateral cerebral ventricle of anesthetized mice. Successful cannula placement was verified in four *Six3Cre;Lhx1*^lox/lox^ and four *Lhx1* ^lox/lox^ mice by measuring feeding after NPY i.c.v. injection. A total of 2 μl of 114 μM Prok2, Grp, or saline vehicle was i.c.v. injected under dim red light into mice free-running in DD, at estimated CT 14. See [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"} for details.

Optomotry {#S30}
---------

Behavior was assessed as described previously ([@R14]). Briefly, animals were adapted for 5 min to an elevated platform centered in a virtual cylinder. A sine wave grating was presented and acuity was assessed by the staircase method; stimulus tracking was recorded from above. Each mouse was tested in triplicate.

Pupillary Light Reflex {#S31}
----------------------

Behavior was assessed as described previously ([@R14]). Briefly, pupil size of one eye was video recorded for 15 s after 1 hr dark adaptation and then 30 s while the opposite eye was stimulated with a 470 nm light-emitting diode. Percent constriction relative to dark-adapted baseline was calculated from images captured from the video. Measurements were restricted to midday (ZT 4--8). Responses to low (22 μW cm^2^) and high (5.66 mW cm^2^) light intensities were recorded.

Motif Pair Tree Bioinformatic Analysis {#S32}
--------------------------------------

The Lhx1 transcription factor binding site position weight matrix was downloaded from the Bulyk PDM Database (<http://the_brain.bwh.harvard.edu/pbms/webworks2/explore.php>). Proximal enhancer regions (2 kb upstream and 1kb downstream of transcription start site) were extracted from annotated reference genes, and only sequences conserved between mouse and human genomes were considered. We identified Lhx1 binding sites with motif pair tree (MOPAT) software ([@R26]), with 0.0001 as the p value cutoff defining positive hits.
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![Lhx1 Effects on SCN Neuropeptides\
(A--F') ISH of SCN from adult *Lhx1*^lox/lox^ control (A--F) and *Six3-Cre;Lhx1*^lox/lox^ mutant (A'--F') mice for *Vip* (A, A'), *Prok2* (B, B'), *Grp* (C, C'), *Avp* (D, D'), *Enk* (E, E'), and *Nms* (F, F'). Insets show the neocortex (A and C), preoptic area (B, E, and F), and paraventricular nucleus (D). Scale bar represents 100 μm.\
(G) Mutants had fewer neuropeptide ISH-labeled SCN cells than controls (n = 3, paired two-tailed t tests, \*p \< 0.05, \*\*p \< 0.01; graph depicts mean ± SEM).\
(H) MOPAT bioinformatics analysis showed more putative Lhx1-binding sites in enhancers of an SCN-enriched gene pool compared to a randomly selected pool (pool shown in [Table S2](#SD1){ref-type="supplementary-material"}; method described in [@R26]; binomial distribution, \*p \< 0.05).](nihms-644878-f0001){#F1}

![SCN Regional Identity Is Pre-served in *Six3-Cre;Lhx1*^lox/lox^ Mice, but Cell Death Is Elevated in Neonatal SCN\
(A--D) ISH of SCN from Lhx1^lox/lox^ control (A--D) and *Six3-Cre;Lhx1*^lox/lox^ adult mutant (A^0^--D^0^) mice for *Gad67* (A, A'), *Calb1* (B, B'), *Calb2* (C, C'), and *Vipr2* (D, D').\
(E) Mutants had fewer SCN neurons than controls at P4 and P7 (n = 3, 3, 3, 3, ANOVA and Tukey post hoc tests, \*p \< 0.05, \*\*\*p \< 0.0005; graph depicts mean ± SEM). Mutant SCN neuron number in adults was significantly lower than controls when initially analyzed on its own by t test (p \< 0.05) but fell just short of significance in the context of the time course (p = 0.07).\
(F) Mutants had increased SCN cell death in the aggregate period between P0 and P3 compared to controls, but the age(s) within this range with elevated cell death could not be pinned down (n = 3, 4, 4, 3, ANOVA with post hoc Tukey tests, \*\*p \< 0.005; graph depicts mean ± SEM).\
(G) Mutants had fewer *Vip*, *Grp*, *and Avp*, but not *Prok2*, expressing SCN cells than controls at P0 (n = 3, 3, 3, 3, paired two-tailed t tests, \*p \< 0.05; graph depicts mean ± SEM).](nihms-644878-f0002){#F2}

![Lhx1 Effects on SCN Clock Gene Rhythms\
(A) Adult *Lhx1*^lox/lox^ (left) and *Six3-Cre;Lhx1*^lox/lox^ (right) mouse SCN explants showed near-24 hr cycling of Per2::Luc bioluminescence over 10 days of recording, with moderately damped amplitude in the mutant explants. Traces show mean (black line) and SD (gray) of bioluminescence collected at 1 min intervals from 8 *Lhx1*^lox/lox^ (left) and 9 *Six3-Cre; Lhx1*^lox/lox^ (right) explants.\
(B) Raster plots demonstrate variations in synchrony of circadian rhythms across regions of interest (ROIs) from one representative control (left) and one Six3Cre;Lhx1^lox/lox^ SCN explant (right). White bars cover the region where data were lost while recording (40--46 hr).\
(C) Loss of Lhx1 caused greater variance of circadian period in *Six3-Cre;Lhx1*^lox/lox^ SCN explants (n = 5) compared to control littermates (n = 8).\
(D--F) Circadian variation in expression levels of SCN clock genes *Per2* (D), *Per2* (E), *Bmal1* (C), and *Avp* (F). ISH labeling intensity was present in adult *Lhx1*^lox/lox^ control (D--F) and *Six3-Cre;Lhx1*^lox/lox^ mutant (D'--F') mice, with genotype and interaction effects for some genes (n = 3, ANOVA).](nihms-644878-f0003){#F3}

![Loss of Lhx1 in the SCN Influences Photoentrainment and Leads to Loss of Free-Running Circadian Rhythms\
(A and A') Representative actograms of wheel-running activity of *Lhx1*^lox/lox^ (A) and *Six3-Cre; Lhx1*^lox/lox^ (A') housed in a 12 hr:12 hr light:dark cycle and subject to a 6 hr advance in the light/dark cycle. Gray shading represents lights off.\
(B) *Six3-Cre; Lhx1*^lox/lox^ mice show a decreased percentage of activity confined to the dark portion of the light/dark cycle (n = 10,13; p = 0.0002).\
(C) *Six3-Cre; Lhx1*^lox/lox^ mice show an advanced phase angle in 12:12 LD (n = 10, 11; p = 0.02). Data represent mean ± SEM. \*\*\*p \< 0.001, \*p \< 0.05.\
(D and D') Representative actograms of wheel-running activity of *Lhx1*^lox/lox^ (D) and *Six3-Cre; Lhx1*^lox/lox^ (D') mice housed in constant darkness. *Six3-Cre; Lhx1*^lox/lox^ mice showed either arrhythmicitiy or split rhythms under DD.\
(E) Quantification of free-running circadian period lengths in DD. Period lengths for *Six3-Cre; Lhx1*^lox/lox^ are those found in mice with split rhythms. The multiple period lengths measured within a single animal are indicated by the same symbol in the mutant graph. (F) Distribution of circadian phenotypes observed in *Six3-Cre;Lhx1*^lox/lox^ mice.\
(G) *Lhx1*^lox/lox^ activity is decreased in constant light as compared to constant darkness. This difference was not observed in *Six3-Cre; Lhx1*^lox/lox^ mice (n = 9--11 per group; two-way ANOVA p~light~ = 0.02, p~genotype~ = 0.02, Bonferroni posttest Lhx1^lox/lox^ DD versus LL, p \< 0.05). Data represent mean ± SEM. \*p \< 0.05.](nihms-644878-f0004){#F4}

![The *Lhx1*-Deficient Circadian System Is Hypersensitive to Cannulation of the SCN Output Molecule Prok2\
(A--C) Representative actograms of wheel-running activity of *Lhx1*^lox/lox^ (A--C) and *Six3-Cre;Lhx1*^lox/lox^ (A'--C') mice before and after an i.c.v. injection (red asterisk) of saline (A), Grp (B), or Prok2 (C) in DD.\
(D and E) Mutants had higher-magnitude phase shifts (D) and period shifts (E) in response to Prok2 than controls (left) (n = 8, two-tailed heteroscedastic t tests, \*p \< 0.05; bar graphs depict mean ± SEM). Both phase and period shifts in mutants were gated by injection CT (right) (n = 5, linear regression, scatterplots depict CT versus phase or period shift of individual injections).\
(F) A model of SCN neuropeptide dynamics. Synchronizing factors are shown in green, desynchronizing factors are shown in red, and factors without clear implications for synchrony are shown in black. The following insights gained from our study are highlighted: (i) synchronizing and desynchronizing effects of SCN signals like Grp can be contingent on interpretation by the broader network, and (ii) core neuropeptides may buffer circadian period length, stabilizing it in the face of feedback signaling from SCN outputs like Prok2 that would otherwise alter it.](nihms-644878-f0005){#F5}
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